Research Article
Towards Automated Multiclass Severity Prediction Approach for COVID-19 Infections Based on Combinations of Clinical Data
Table 1
Clinical, laboratory, vital function, and medical history information collected from hospital records.
| | Characteristics | Overall appearance |
| | Age, mean (years) | 52.83 |
| | Gender, n (%) | | Male | 46 (58.97%) | | Female | 32 (41.03%) |
| | Chronic diseases, n (%) | | Chronic medical illness (hypertension, diabetes, and tumor or any type of cancer) | 41 (52.56%) |
| | Outcomes, n (%) | | Mortality rate | 11 (14.1%) | | Survival rate | 67 (85.9%) |
| | Symptoms onset, n (%) | | Fever | 53 (67.95%) | | Cough | 46 (58.97%) | | Generalized weakness | 52 (66.67%) | | Nasal congestion | 33 (42.30%) | | Rhinorrhea | 33 (42.30%) | | Sneezing | 44 (56.41%) | | Sore throat | 45 (57.69%) | | Pleuritic chest pain | 42 (53.84%) | | Diarrhoea | 41 (52.56%) | | Lost sense of smell | 71 (91.02%) | | Lost sense of taste | 72 (92.30%) |
| | Laboratory test, n: abnormal cases based on WHO test range (%) | | Hemoglobin (g/dL) | M: 11 (23.91%), F: 15 (46.87%) | | White blood cell count | 31 (39.74%) | | Lymphocyte count | 13 (16.66%) | | Platelet count | 13 (16.66%) | | C-reactive protein (mg/L) | 48 (61.53%) | | Urea (mmol/L) | 22 (28.20%) | | Creatinine (µmol/L) | 56 (71.79%) |
| | Vital signs, n: abnormal cases based on WHO test range (%) | | Saturation of oxygen in the blood (SpO2), (>90, 90–94, and 95–100) | 46 (58.97%), 21 (26.93%), and 11 (14.10%) |
|
|
